Australia markets closed

Silo Pharma, Inc. (SILO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.9760+0.0160 (+0.82%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
72.102
72.102
72.102
71.264
0
Cost of revenue
5.838
5.838
5.838
5.004
0
Gross profit
66.264
66.264
66.264
66.26
0
Operating expenses
Research development
845.092
845.092
1,286
693.91
26.25
Selling general and administrative
3,077
3,077
2,427
2,265
2,010
Total operating expenses
3,922
3,922
3,714
2,959
2,036
Operating income or loss
-3,856
-3,856
-3,648
-2,893
-2,036
Interest expense
4.869
4.869
2.199
3.036
269.267
Total other income/expenses net
-169.152
-169.152
-330.17
7,077
-372.202
Income before tax
-3,631
-3,631
-3,907
4,182
-2,666
Income tax expense
0
0
0
24.876
0
Income from continuing operations
-3,631
-3,631
-3,907
4,157
-2,666
Net income
-3,701
-3,701
-3,909
3,904
-3,038
Net income available to common shareholders
-3,701
-3,701
-3,909
2,500
-3,107
Basic EPS
-1.40
-
-1.71
1.32
-2.50
Diluted EPS
-1.40
-
-1.71
1.30
-2.50
Basic average shares
3,149
-
2,284
1,897
1,319
Diluted average shares
3,149
-
2,284
1,918
1,319